ArticleFrontiers in immunology2022

IMPDH1, a prognostic biomarker and immunotherapy target that correlates with tumor immune microenvironment in pan-cancer and hepatocellular carcinoma.

Chengdong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.